Cambridge
United Kingdom
45
2024-11-07
The entities that hold a legal rights for patent applications filed by inventor Murray Christopher William:
Christopher William Murray from Cambridge, GB has applied for patents for these inventions. The list has both pending applications and granted patents:
BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS
#2 | 2023-01-19Benzolactam compounds as protein kinase inhibitors
#3 | 2022-05-05PYRAZOLYL QUINOXALINE KINASE INHIBITORS
#4 | 2020-04-30PYRAZOLYL QUINOXALINE KINASE INHIBITORS
#5 | 2019-02-14Benzolactam compounds as protein kinase inhibitors
#6 | 2018-05-10Pyrazolyl quinoxaline kinase inhibitors
#7 | 2017-01-05Pteridines as FGFR inhibitors
#8 | 2016-10-27Pyrazolyl quinoxaline kinase inhibitors
#9 | 2016-08-04Substituted quinoxalines as FGFR kinase inhibitors
#10 | 2016-02-04Substituted quinoxalines as FGFR kinase inhibitors
#11 | 2015-12-10Bicyclic heterocycle compounds and their uses in therapy
#12 | 2015-10-15Pteridines as FGFR inhibitors
#13 | 2015-09-17Bicyclic heterocycle compounds and their uses in therapy
#14 | 2015-04-16Pyrazolyl quinoxaline kinase inhibitors
#15 | 2015-02-12Hydroxybenzamide derivatives and their use as inhibitors of HSP90
#16 | 2015-01-29Substituted quinoxalines as FGFR kinase inhibitors
#17 | 2013-10-10Substituted quinoxalines as FGFR kinase inhibitors
#18 | 2013-03-21Pyrazolyl quinoxaline kinase inhibitors
#19 | 2012-10-04Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90
#20 | 2012-08-16Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases
#21 | 2012-03-06FGFR pharmacophore compounds
#22 | 2012-02-16Imidazo [1,2-A]pyridine derivatives as FGFR kinase inhibitors for use in therapy
#23 | 2012-02-09Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
#24 | 2012-02-09Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
#25 | 2011-05-05Pharmaceutical combinations
#26 | 2010-12-30Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
#27 | 2010-11-11Dihydroxyphenyl isoindolylmethanones
#28 | 2010-11-11Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
#29 | 2010-08-26HYDROXYBENZAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF HSP90
#30 | 2010-07-15Pharmaceutical combinations
#31 | 2010-06-17Pharmaceutical compounds
#32 | 2010-05-13Bicyclic heterocyclic compounds as FGFR inhibitors
#33 | 2010-04-15Imidazo[1,2-a]pyridine compounds for use in treating cancer
#34 | 2010-04-15Pharmaceutical combinations
#35 | 2009-09-03Substituted Amino-Compounds and Uses Thereof
#36 | 2009-08-27Pyrimidine Derivatives As HSP90 Inhibitors
#37 | 2009-03-05Substituted Amino-Pyrimidones and Uses Thereof
#38 | 2008-11-20Substituted Aminopyridines and Uses Thereof
#39 | 2007-11-29Hydroxybenzamide derivatives and their use as inhibitors of Hsp90
#40 | 2007-11-08Dihydroxyphenyl isoindolymethanones
#41 | 2007-11-08Hydroxybenzamide derivatives and their use as inhibitors of Hsp90
#42 | 2007-03-29Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders
#43 | 2006-07-18Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders
#44 | 2006-06-01Crystals of cytochrome P450 2C9, structures thereof and their use
#45 | 2006-03-233-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
154175 ⎘